ADC Therapeutics SA Annual Net Income (Loss) Attributable to Parent in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ADC Therapeutics SA quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to 2023.
  • ADC Therapeutics SA Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$36.5M, a 25.3% increase year-over-year.
  • ADC Therapeutics SA annual Net Income (Loss) Attributable to Parent for 2023 was -$240M, a 52.8% decline from 2022.
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$240M -$82.9M -52.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$157M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.